WiSA Technologies, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)

CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands	Preferred Stock Convertible Preferred Stock	Preferred Stock Series B preferred stock	Common Shares Series B preferred stock	Common Shares Convertible Promissory Note	Common Shares	Additional Paid-in Capital Series B preferred stock	Additional Paid-in Capital Convertible Promissory Note	Additional Paid-in Capital	Accumulated Deficit ASC842 adoption adjustment	Accumulated Deficit	ASC842 adoption adjustment	Series B preferred stock	Convertible Promissory Note	Total
Balance at Dec. 31, 2021	$ 0				$ 2			$ 228,578		$ (212,203)				$ 16,377
Balance (in shares) at Dec. 31, 2021					158,310									0
Stock-based compensation								2,027						$ 2,027
Stock-based compensation (in shares)					12,749
Release of vested restricted common stock (in shares)					2,108
Restricted stock awards cancelled (in shares)					(603)
Issuance of warrants in connection with convertible promissory note								91						91
Issuance of common stock and warrants, net of offering costs					$ 5			6,426						6,431
Issuance of common stock and warrants, net of offering costs (in shares)					540,000
Issuance of warrants in connection with December 2022 offering								(10,804)						(10,804)
Net loss										(16,151)				(16,151)
Balance at Dec. 31, 2022	0				$ 7			226,318	$ 33	(228,321)	$ 33			(1,996)
Balance (in shares) at Dec. 31, 2022					712,564
Issuance of common stock in connection with warrant exercise								10,713						10,713
Issuance of common stock in connection with warrant exercise (in shares)					2,854,485
Convertible preferred stock dividend	$ 6,063
Deemed dividend on conversion of convertible preferred for common stock								(6,063)						(6,063)
Stock-based compensation								2,058						2,058
Stock-based compensation (in shares)					964,041
Release of vested restricted common stock (in shares)					2,919
Restricted stock awards cancelled (in shares)					(13,288)
Issuance of common stock in connection with conversion of Series B preferred stock						$ 6,341	$ 708					$ 6,341	$ 708	6,341
Issuance of common stock in connection with convertible securities (In shares)			26,592,199	67,500
Issuance of common stock and warrants, net of offering costs								2,319						2,319
Issuance of common stock and warrants, net of offering costs (in shares)					2,176,435
Issuance of Series B preferred stock, net of discounts						1,909						1,909
Issuance of Series B preferred stock, net of discount (in shares)	87,000
Issuance of Series B preferred stock in connection with warrant exercise, net of discounts		$ 3,550				195						195
Issuance of Series B preferred stock in connection with warrant exercise, net of discounts (in shares)	61,613
Issuance of common stock in connection with conversion of Series B preferred stock		(6,341)
Issuance of common stock in connection with conversion of Series B preferred stock (in shares)	(110,278)
Repurchase of common stock warrants								(2,323)						(2,323)
Amortization and accretion of discounts relating to Series B preferred stock		297				$ (297)						$ (297)
Discount from issuance of common stock warrants in connection with Series B preferred stock inducement		$ (3,322)
Net loss										(18,721)				(18,721)
Balance at Dec. 31, 2023	$ 247				$ 7			$ 241,878		$ (247,042)				$ (5,157)
Balance (in shares) at Dec. 31, 2023	38,335				33,356,855